FI903818A0 - 1-(pyridinylamino)-2-pyrrolidoner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel. - Google Patents

1-(pyridinylamino)-2-pyrrolidoner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.

Info

Publication number
FI903818A0
FI903818A0 FI903818A FI903818A FI903818A0 FI 903818 A0 FI903818 A0 FI 903818A0 FI 903818 A FI903818 A FI 903818A FI 903818 A FI903818 A FI 903818A FI 903818 A0 FI903818 A0 FI 903818A0
Authority
FI
Finland
Prior art keywords
pyridinylamino
deras
pyrrolidoner
foerfarande foer
framstaellning och
Prior art date
Application number
FI903818A
Other languages
English (en)
Finnish (fi)
Inventor
Richard Charles Effland
David Gordon Wettlaufer
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of FI903818A0 publication Critical patent/FI903818A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI903818A 1989-08-02 1990-07-31 1-(pyridinylamino)-2-pyrrolidoner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel. FI903818A0 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/388,413 US4994472A (en) 1989-08-02 1989-08-02 1-(pyridinylamino)-2-pyrrolidinones as pain relievers

Publications (1)

Publication Number Publication Date
FI903818A0 true FI903818A0 (fi) 1990-07-31

Family

ID=23534027

Family Applications (1)

Application Number Title Priority Date Filing Date
FI903818A FI903818A0 (fi) 1989-08-02 1990-07-31 1-(pyridinylamino)-2-pyrrolidoner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.

Country Status (17)

Country Link
US (1) US4994472A (fr)
EP (1) EP0413191B1 (fr)
JP (1) JPH0674264B2 (fr)
KR (1) KR0164437B1 (fr)
AT (1) ATE109142T1 (fr)
AU (1) AU635051B2 (fr)
CA (1) CA2022484C (fr)
DE (1) DE69011013T2 (fr)
DK (1) DK0413191T3 (fr)
ES (1) ES2059929T3 (fr)
FI (1) FI903818A0 (fr)
IE (1) IE65117B1 (fr)
IL (1) IL95250A (fr)
NO (1) NO903388L (fr)
NZ (1) NZ234724A (fr)
PT (1) PT94878B (fr)
ZA (1) ZA906049B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356908A (en) * 1989-04-21 1994-10-18 E. I. Du Pont De Nemours And Company Fungicidal oxazolidinones
IE904673A1 (en) * 1989-12-27 1991-07-17 Monsanto Co Substituted pyridine compounds
AUPM656594A0 (en) * 1994-06-30 1994-07-21 Orbital Engine Company (Australia) Proprietary Limited A method and apparatus relating to control of the operation of an internal combustion engine
IL126308A0 (en) * 1996-04-12 1999-05-09 Hoechst Marion Roussel Inc Isatin derivatives as acetylcholinesterase inhibitors and analgesics
US6100276A (en) * 1996-04-12 2000-08-08 Aventis Pharmaceuticals Inc. Isatin derivatives as acetylcholinesterase inhibitors and analgesics
US20050065205A1 (en) 2002-03-07 2005-03-24 Daniel Alkon Methods for Alzheimer's disease treatment and cognitive enhance
US6825229B2 (en) 2002-03-07 2004-11-30 Blanchette Rockefeller Neurosciences Institute Methods for Alzheimer's Disease treatment and cognitive enhancement
AU2003281214A1 (en) * 2002-07-02 2004-01-23 Blanchette Rockefeller Neurosciences Institute PKC ACTIVATION AS A MEANS FOR ENHANCING sAPPAlpha SECRETION AND IMPROVING COGNITION USING BRYOSTATIN TYPE COMPOUNDS
TW201207390A (en) 2004-05-18 2012-02-16 Brni Neurosciences Inst Method for screening agent for antidepressant activity
GB0412019D0 (en) * 2004-05-28 2004-06-30 Novartis Ag Organic compounds
CA2617003A1 (fr) 2005-07-29 2007-02-08 Blanchette Rockefeller Neurosciences Institute Utilisation d'un activateur de pkc seul ou combine a un inhibiteur de pkc pour renforcer la memoire a long terme
EP2121000B1 (fr) 2007-02-09 2015-09-23 Blanchette Rockefeller Neurosciences, Institute Effets thérapeutiques des bryostatines, de leurs analogues, et d'autres substances connexes sur l'affaiblissement de la mémoire induite par un traumatisme crânien et sur les lésions cérébrales

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670184A1 (de) * 1967-01-20 1971-01-21 Boehringer Sohn Ingelheim Verfahren zur Herstellung heterocyclisch substituierter Hydrazino-imidazoline-(2)
US4260767A (en) * 1979-12-26 1981-04-07 American Cyanamid Company 2-Pyridylhydrazides
US4324884A (en) * 1980-09-25 1982-04-13 General Electric Company Organic amine catalyzed method for making polyetherimide
US4792562A (en) * 1985-12-04 1988-12-20 Hoechst-Roussel Pharmaceuticals, Inc. N-(pyrrol-1-yl)pyridinamines having memory enhancing activity
US4752610A (en) * 1985-12-04 1988-06-21 Hoechst-Roussel Pharmaceuticals Inc. N-(pyrrol-1-yl)pyridinamines having memory enhancing properties
JPH0699307B2 (ja) * 1987-08-20 1994-12-07 キッセイ薬品工業株式会社 抗痴呆剤
US4868190A (en) * 1988-12-27 1989-09-19 Hoechst-Roussel Pharmaceuticals, Inc. N-pyridinyl-9H-carbazol-9-amines

Also Published As

Publication number Publication date
KR910004597A (ko) 1991-03-29
KR0164437B1 (ko) 1999-01-15
NO903388L (no) 1991-02-04
ZA906049B (en) 1991-04-24
US4994472A (en) 1991-02-19
ES2059929T3 (es) 1994-11-16
AU635051B2 (en) 1993-03-11
NZ234724A (en) 1992-01-29
PT94878B (pt) 1997-08-29
EP0413191A1 (fr) 1991-02-20
EP0413191B1 (fr) 1994-07-27
IE65117B1 (en) 1995-10-04
DK0413191T3 (da) 1994-10-24
CA2022484A1 (fr) 1991-02-03
IL95250A (en) 1994-01-25
IL95250A0 (en) 1991-06-10
DE69011013D1 (de) 1994-09-01
JPH0674264B2 (ja) 1994-09-21
CA2022484C (fr) 2000-10-17
JPH0368572A (ja) 1991-03-25
ATE109142T1 (de) 1994-08-15
IE902786A1 (en) 1991-02-27
PT94878A (pt) 1991-04-18
AU6000290A (en) 1991-02-07
DE69011013T2 (de) 1994-12-22
NO903388D0 (no) 1990-08-01

Similar Documents

Publication Publication Date Title
AU6208990A (en) N-substituted-4-pyrimidinamines and pyrimidindiamines, a process for their preparation and their use as medicaments
FI903819A0 (fi) 1,3-dihydro-1-(pyridinylamino)-2h-indol- 2-oner, foerfarande foer framstaellning av dem och anvaendning av dem som laekemedel.
FI903818A0 (fi) 1-(pyridinylamino)-2-pyrrolidoner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
NO903390D0 (no) Fremgangsmaate for fremstilling av 2,3-dihydro-1-(pyridinylamino)-indoler og deres anvendelse som legemidler.

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED